Precigen Inc
NASDAQ:PGEN

Watchlist Manager
Precigen Inc Logo
Precigen Inc
NASDAQ:PGEN
Watchlist
Price: 1.93 USD 9.66% Market Closed
Market Cap: 569.7m USD

EV/FCFF
Enterprise Value to FCFF

-6.1
Current
-4.1
Median
3.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-6.1
=
Enterprise Value
461.3m USD
/
FCFF
-75.3m USD
 
US
Precigen Inc
NASDAQ:PGEN
Average EV/FCFF: 25
Negative Multiple: -6.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 741.5
US
Abbvie Inc
NYSE:ABBV
26.4
US
Amgen Inc
NASDAQ:AMGN
18.1
US
Gilead Sciences Inc
NASDAQ:GILD
15.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -522.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -73.8
AU
CSL Ltd
ASX:CSL
49.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -1 031.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -63.2

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A